What makes the novel coronavirus so scary isn’t necessarily the incredible infectiousness of the pathogen, although that’s certainly part of the reason why people are so afraid of COVID-19. The real problem is the fact that there are currently no available drugs that can prevent severe cases and life-threatening complications. The new illness has often been compared to the flu, but the past few months have shown us that the comparison is flat-out wrong. The many viruses that cause the flu are also dangerous for humans without proper care, but we tend not to panic about a flu case because we know how to treat it at home long before we need to call in the cavalry. It might be a while until we can treat COVID-19 at home, as scientists have yet to determine treatment protocols that can be applied outside of hospitals. After all, vaccines alone won’t put an end to the pandemic because the virus will continue to spread.
Doctors worldwide have been studying all sorts of therapies to manage COVID-19 and reduce complications. Now, a team of scientists from Florida thinks it has figured out an optimal protocol and they say their COVID-19 treatment has a near-perfect success rate.
“The ICAM protocol has the potential to trigger the reopening of the country,” Director of Pharmacy at AdventHealth Ocala Dr. Carlette Norwood-Williams told Fox 35. “We will know the next step after our outpatient study.”
The scientists have not yet tested their combination of drugs in a clinical trial to prove beyond any doubt that the treatment is safe and effective. But according to the researchers, ICAM therapy has yielded a 96.4% survival rate since April. It’s unclear how many patients have received ICAM, but Florida was one of the hardest-hit states in the US over the summer.
ICAM isn’t a new drug, it’s an acronym for a combination of existing medications used simultaneously on patients. It uses Immunosupport drugs (Vitamin C and Zinc), Corticosteroids against inflammation, Anticoagulants against blood clots, and Macrolides to help fight infection…Read more>>